Duke Health

In September 2025, Louisiana sheriff’s deputy Nick Lege was suffering from heart failure and liver damage when he arrived via medical flight to Duke University Hospital. Two months later, Lege underwent a combined heart-liver transplant, which is only offered at a few hospitals in the Southeast. Today, 46-year-old Lege credits Duke for saving his life. “I am so grateful for the opportunity to go to Duke and get this kind of high-class care,” Lege said. “It means so much to me.”

For nearly 25 years, Juli Brockmann, 58, had debilitating facial pain that brought her once fulfilling life to a grinding halt. Even with powerful medications, Brockmann’s pain kept her mostly bedbound. In September 2025, Brockmann was implanted with a spinal cord stimulator at Duke Health. It quiets the pain signals coming from the damaged facial nerves causing Brockmann’s pain. “I am Juli again,” she said. “I can clean my house. I can take my dog for a walk. I can get up and shower. I never dreamt that I could be this person again.”

Ned Steele has tried many treatments in the 18 years he’s been living with prostate cancer, but none has worked better than PLUVICTO®. Thanks to the efforts of Duke Health medical oncologist Daniel George, MD, and the team at Duke Cancer Institute, Steele was an early user of PLUVICTO for prostate cancer, receiving treatment through a clinical trial before it was FDA-approved in 2022. “PLUVICTO is a miracle drug,” said Steele.